Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Yong Liu; Xiangwei Zhang; Zhaofei Pang; Yadong Wang; Haotian Zheng; Guanghui Wang; Kai Wang; Jiajun Du

doi:doi:10.18632/aging.205838

← Back

Research Paper Volume 16, Issue 10 pp 8772—8809

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Figure 5. Evaluation of MPPS model in pan-cancer. (A) The Kaplan-Meier analysis of the high- and low-risk groups across 32 tumors in TCGA database except LUAD. The survival analysis was tested by log-rank test. (B–D) The 1-, 3-, 5-year AUC of MPPS model across 32 tumors in TCGA database except LUAD.